erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
it's the first successful medical treatment of a human fetus for the underlying cause of a genetic disorder, experts say
.
.
"future placement of tooth implants if needed will be much easier," he said.
.
he added: �these findings show that despite the tireless work of doctors and nurses, it appears that some cancer patients are still enduring shockingly long waits to start treatment.
.